Literature DB >> 23730221

Identification of patients at risk for hereditary colorectal cancer.

Nitin Mishra1, Jason Hall.   

Abstract

Diagnosis of hereditary colorectal cancer syndromes requires clinical suspicion and knowledge of such syndromes. Lynch syndrome is the most common cause of hereditary colorectal cancer. Other less common causes include familial adenomatous polyposis (FAP), Peutz-Jeghers syndrome (PJS), juvenile polyposis syndrome, and others. There have been a growing number of clinical and molecular tools used to screen and test at risk individuals. Screening tools include diagnostic clinical criteria, family history, genetic prediction models, and tumor testing. Patients who are high risk based on screening should be referred for genetic testing.

Entities:  

Keywords:  Lynch syndrome; Peutz-Jeghers syndrome; familial adenomatous polyposis

Year:  2012        PMID: 23730221      PMCID: PMC3423884          DOI: 10.1055/s-0032-1313777

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  166 in total

1.  The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer.

Authors:  W S Samowitz; K Curtin; H H Lin; M A Robertson; D Schaffer; M Nichols; K Gruenthal; M F Leppert; M L Slattery
Journal:  Gastroenterology       Date:  2001-10       Impact factor: 22.682

Review 2.  Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature.

Authors:  M H Nieuwenhuis; H F A Vasen
Journal:  Crit Rev Oncol Hematol       Date:  2006-10-24       Impact factor: 6.312

Review 3.  Familial adenomatous polyposis.

Authors:  Polymnia Galiatsatos; William D Foulkes
Journal:  Am J Gastroenterol       Date:  2006-02       Impact factor: 10.864

4.  Peutz-Jeghers families unlinked to STK11/LKB1 gene mutations are highly predisposed to primitive biliary adenocarcinoma.

Authors:  S Olschwang; C Boisson; G Thomas
Journal:  J Med Genet       Date:  2001-06       Impact factor: 6.318

5.  MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer.

Authors:  Françoise Charbonnier; Sylviane Olschwang; Qing Wang; Cécile Boisson; Cosette Martin; Marie-Pierre Buisine; Alain Puisieux; Thierry Frebourg
Journal:  Cancer Res       Date:  2002-02-01       Impact factor: 12.701

6.  Deciphering the genetics of hereditary non-syndromic colorectal cancer.

Authors:  Eli Papaemmanuil; Luis Carvajal-Carmona; Gabrielle S Sellick; Zoe Kemp; Emily Webb; Sarah Spain; Kate Sullivan; Ella Barclay; Steven Lubbe; Emma Jaeger; Jayaram Vijayakrishnan; Peter Broderick; Maggie Gorman; Lynn Martin; Anneke Lucassen; D Timothy Bishop; D Gareth Evans; Eamonn R Maher; Verena Steinke; Nils Rahner; Hans K Schackert; Timm O Goecke; Elke Holinski-Feder; Peter Propping; Tom Van Wezel; Juul Wijnen; Jean-Baptiste Cazier; Huw Thomas; Richard S Houlston; Ian Tomlinson
Journal:  Eur J Hum Genet       Date:  2008-07-16       Impact factor: 4.246

7.  Increased colorectal cancer incidence in obligate carriers of heterozygous mutations in MUTYH.

Authors:  Natalie Jones; Stefanie Vogt; Maartje Nielsen; Daria Christian; Petra A Wark; Diana Eccles; Emma Edwards; D Gareth Evans; Eamonn R Maher; Hans F Vasen; Frederik J Hes; Stefan Aretz; Julian R Sampson
Journal:  Gastroenterology       Date:  2009-04-23       Impact factor: 22.682

8.  A case of Cronkhite-Canada syndrome: remission after treatment with anti-Helicobacter pylori regimen.

Authors:  Kenta Okamoto; Hajime Isomoto; Saburo Shikuwa; Hitoshi Nishiyama; Masahiro Ito; Shigeru Kohno
Journal:  Digestion       Date:  2008-10-24       Impact factor: 3.216

9.  Formation of 8-hydroxy-2'-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in human renal-cell carcinoma.

Authors:  K Okamoto; S Toyokuni; K Uchida; O Ogawa; J Takenewa; Y Kakehi; H Kinoshita; Y Hattori-Nakakuki; H Hiai; O Yoshida
Journal:  Int J Cancer       Date:  1994-09-15       Impact factor: 7.396

10.  Germline susceptibility to colorectal cancer due to base-excision repair gene defects.

Authors:  Susan M Farrington; Albert Tenesa; Rebecca Barnetson; Alice Wiltshire; James Prendergast; Mary Porteous; Harry Campbell; Malcolm G Dunlop
Journal:  Am J Hum Genet       Date:  2005-05-03       Impact factor: 11.025

View more
  7 in total

1.  Epithelial-mesenchymal transition in colorectal cancer tissue of patients with Lynch syndrome.

Authors:  Guo-Li Gu; Xiao-Quan Zhu; Xue-Ming Wei; Li Ren; De-Chang Li; Shi-Lin Wang
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 2.  Genetic risks and familial associations of small bowel carcinoma.

Authors:  Santosh Shenoy
Journal:  World J Gastrointest Oncol       Date:  2016-06-15

3.  Oncologists' Selection of Genetic and Molecular Testing in the Evolving Landscape of Stage II Colorectal Cancer.

Authors:  Aparna R Parikh; Nancy L Keating; Pang-Hsiang Liu; Stacy W Gray; Carrie N Klabunde; Katherine L Kahn; David A Haggstrom; Sapna Syngal; Benjamin Kim
Journal:  J Oncol Pract       Date:  2016-03       Impact factor: 3.840

Review 4.  Tumor suppressor genes in familial adenomatous polyposis.

Authors:  Nahal Eshghifar; Naser Farrokhi; Tahereh Naji; Mohammadreza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017

5.  Identification of novel pathogenic MSH2 mutation and new DNA repair genes variants: investigation of a Tunisian Lynch syndrome family with discordant twins.

Authors:  Amira Jaballah-Gabteni; Haifa Tounsi; Maria Kabbage; Yosr Hamdi; Sahar Elouej; Ines Ben Ayed; Mouna Medhioub; Moufida Mahmoudi; Hamza Dallali; Hamza Yaiche; Nadia Ben Jemii; Afifa Maaloul; Najla Mezghani; Sonia Abdelhak; Lamine Hamzaoui; Mousaddak Azzouz; Samir Boubaker
Journal:  J Transl Med       Date:  2019-06-27       Impact factor: 5.531

6.  Metagenomic analysis of formalin-fixed paraffin-embedded tumor and normal mucosa reveals differences in the microbiome of colorectal cancer patients.

Authors:  Gabriela Debesa-Tur; Vicente Pérez-Brocal; Susana Ruiz-Ruiz; Adela Castillejo; Amparo Latorre; José Luis Soto; Andrés Moya
Journal:  Sci Rep       Date:  2021-01-11       Impact factor: 4.379

7.  Chemoprevention of intestinal tumorigenesis by the natural dietary flavonoid myricetin in APCMin/+ mice.

Authors:  Ye Li; Shu-Xiang Cui; Shi-Yue Sun; Wen-Na Shi; Zhi-Yu Song; Shu-Qing Wang; Xin-Feng Yu; Zu-Hua Gao; Xian-Jun Qu
Journal:  Oncotarget       Date:  2016-09-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.